New tools for studying M. abscessus pathogenesis
研究脓肿分枝杆菌发病机制的新工具
基本信息
- 批准号:9107388
- 负责人:
- 金额:$ 15.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-07 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:BacteriaBiologyDevelopmentElderlyElderly womanGene MutationGenus MycobacteriumGoalsHumanImmunocompetentImmunocompromised HostIndividualInfectionInterferonsKnock-outLungLung diseasesMethodologyMethodsMicrobial BiofilmsModelingMusMutagenesisMycobacterium tuberculosisNational Institute of Allergy and Infectious DiseaseOperative Surgical ProceduresOrganismPathogenesisPatientsPhenotypePlayPreventionPulmonary PathologyResearchResearch Project GrantsResistanceRoleSite-Directed MutagenesisTNF geneTissuesTreatment ProtocolsTumor Necrosis Factor TherapyUnited States National Institutes of HealthWorkcell envelopecystic fibrosis patientsdesigngenetic manipulationhuman diseaseimprovedin vivokillingsmacrophagemouse modelmutantmycobacterialnovelpathogenprogramspublic health relevanceresearch studysubcutaneoustoolwound
项目摘要
DESCRIPTION (provided by applicant): Mycobacterium abscessus is an emerging pathogen within the rapidly growing, non-tubercular mycobacterial (NTM) species. M. abscessus can cause wound and subcutaneous infections, but the most serious infections are pulmonary, and usually seen in elderly, immunocompetent individuals with underlying lung pathologies, or tall, elderly women with low body mass. Remarkably, M. abscessus is also responsible for serious pulmonary disease in patients with cystic fibrosis or those undergoing anti-TNFα (tumor necrosis factor) therapy. M. abscessus belongs to a taxonomically contentious group "M. abscessus sensu lato", which includes the pathogens M. massiliense and M. bolletii. Recent analysis has suggested that these three organisms are distinct subspecies within the "abscessus" species designation. For the purpose of this proposal, we will focus on M. abscessus senso stricto, otherwise known as M. abscessus subsp. abscessus. The reasons why M. abscessus has become an important NTM in human disease are not clear because M. abscessus is understudied compared to other pathogenic mycobacteria. However, several studies suggest that a morphological switch may play a role in M. abscessus pulmonary pathogenesis. Environmental isolates of M. abscessus typically form smooth colonies, while isolates from patients with deep tissue infections form rough colonies. The emergence of the rough phenotype results from mutation of genes involved with the synthesis or transport of a glycopeptidolipid (GPL) present on the outer leaflet of the cell envelope. Smooth bacteria are GPL+, form biolfilms, and can be killed after engulfment by macrophages. In contrast, the rough, GPL- bacteria do not form biofilms, and are resistant to killing within macrophages. It is hypothesized that the smooth morphotype is better suited for survival in environmental niches and for the initial colonization of the host, while the rough morphotype has a survival advantage deeper in host tissue. In this application, we propose to develop new tools to examine M. abscessus pathogenesis in pulmonary disease within the framework of this hypothesis.
描述(由申请人提供):脓肿分枝杆菌是快速生长的非结核分枝杆菌 (NTM) 物种中的一种新兴病原体,可引起伤口和皮下感染,但最严重的感染是肺部感染,通常见于老年人。 、患有潜在肺部疾病的免疫功能正常的个体,或体重较低的高个子老年女性。值得注意的是,脓肿分枝杆菌也是囊性患者严重肺部疾病的原因。纤维化或接受抗 TNFα(肿瘤坏死因子)治疗的脓肿分枝杆菌属于分类学上有争议的“脓肿分枝杆菌”,其中包括病原体 M. Massiliense 和 M. bolletii。脓肿菌是“脓肿”物种名称中的不同亚种。出于本提案的目的,我们将重点关注脓肿脓肿菌,也称为“脓肿菌”。脓肿分枝杆菌成为人类疾病中重要的 NTM 的原因尚不清楚,因为与其他致病分枝杆菌相比,脓肿分枝杆菌尚未得到充分研究。脓肿分枝杆菌肺部发病机制。脓肿分枝杆菌的环境分离株通常形成光滑菌落,而来自深层感染组织的分离株则形成粗糙菌落。粗糙表型的出现是由于相关基因突变造成的。光滑细菌是 GPL+,可在被巨噬细胞吞噬后被杀死,而粗糙的 GPL- 细菌则不会形成。人们重新认识到,光滑形态更适合在环境生态位中生存和宿主的初始定殖,而粗糙形态则更适合宿主的初始定植。形态型在宿主组织中具有更深的生存优势,我们建议在这一假设的框架内开发新的工具来检查肺部疾病中脓肿分枝杆菌的发病机制。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin S. Pavelka其他文献
Martin S. Pavelka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin S. Pavelka', 18)}}的其他基金
In vivo persistence and immuno-pathogenesis of Mycobacterium abscessus in a new Xenopus tadpole model
脓肿分枝杆菌在新爪蟾蝌蚪模型中的体内持久性和免疫发病机制
- 批准号:
10350750 - 财政年份:2022
- 资助金额:
$ 15.35万 - 项目类别:
In vivo persistence and immuno-pathogenesis of Mycobacterium abscessus in a new Xenopus tadpole model
脓肿分枝杆菌在新爪蟾蝌蚪模型中的体内持久性和免疫发病机制
- 批准号:
10608077 - 财政年份:2022
- 资助金额:
$ 15.35万 - 项目类别:
Analysis of a novel peptidoglycan assembly pathway in mycobacteria
分枝杆菌中新型肽聚糖组装途径的分析
- 批准号:
10203747 - 财政年份:2018
- 资助金额:
$ 15.35万 - 项目类别:
Analysis of a novel peptidoglycan assembly pathway in mycobacteria
分枝杆菌中新型肽聚糖组装途径的分析
- 批准号:
10431963 - 财政年份:2018
- 资助金额:
$ 15.35万 - 项目类别:
New tools for studying M. abscessus pathogenesis
研究脓肿分枝杆菌发病机制的新工具
- 批准号:
8814644 - 财政年份:2015
- 资助金额:
$ 15.35万 - 项目类别:
相似国自然基金
ACAT1蛋白第263位赖氨酸琥珀酰化在ARID1A突变型卵巢癌发生发展中的生物学功能及分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
c-Myc的不同生物学结构域在AML发生发展及白血病干细胞自我更新中的作用
- 批准号:
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
HIF-1α-MIF-CD74/CD44生物学轴在造釉细胞型颅咽管瘤发生发展中的作用及机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
数学生物学发展战略研究与学术交流
- 批准号:
- 批准年份:2020
- 资助金额:10 万元
- 项目类别:专项基金项目
细胞外泌体miR-146a-5p导致脑转移瘤发生发展的分子生物学机制及候选药物研究
- 批准号:82073219
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Oral pathogen - mediated pro-tumorigenic transformation through disruption of an Adherens Junction - associated RNAi machinery
通过破坏粘附连接相关的 RNAi 机制,口腔病原体介导促肿瘤转化
- 批准号:
10752248 - 财政年份:2024
- 资助金额:
$ 15.35万 - 项目类别:
Bio-Responsive and Immune Protein-Based Therapies for Inhibition of Proteolytic Enzymes in Dental Tissues
用于抑制牙齿组织中蛋白水解酶的基于生物响应和免疫蛋白的疗法
- 批准号:
10555093 - 财政年份:2023
- 资助金额:
$ 15.35万 - 项目类别:
Molecular basis of glycan recognition by T and B cells
T 和 B 细胞识别聚糖的分子基础
- 批准号:
10549648 - 财政年份:2023
- 资助金额:
$ 15.35万 - 项目类别:
MAIT cells in lupus skin disease and photosensitivity
MAIT 细胞在狼疮皮肤病和光敏性中的作用
- 批准号:
10556664 - 财政年份:2023
- 资助金额:
$ 15.35万 - 项目类别: